These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 39307761)

  • 1. [Pharmacovigilance guidelines of Chinese patent medicines].
    Wang LX; Wang MM; Li YY; Wang ZF; Cui X; Zhao XX; Liu FM; Yang S; Wei RL; Wang YX; Zhang B; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2024 Aug; 49(16):4261-4265. PubMed ID: 39307761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacovigilance guidelines for clinical application of Chinese patent medicines for external use].
    Cui X; Yang DQ; Xie ZN; Li YY; Wang ZF; Liu H; Liu FM; Zhao XX; Lu ZK; Wang LX; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2024 Aug; 49(16):4285-4290. PubMed ID: 39307765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacovigilance guidelines for clinical application of Chinese patent medicines for mucosal administration].
    Zhao XX; Hua H; Li YY; Wang ZF; Liu FM; Wei RL; Cui X; Yang S; Wang LX; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2024 Aug; 49(16):4291-4297. PubMed ID: 39307766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacovigilance guidelines for clinical application of oral Chinese patent medicines].
    Wang LX; Yang S; Wei RL; Li YY; Cui X; Zhao XX; Peng WX; Liu FM; Wang MM; Li XH; Wang ZF; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2024 Aug; 49(16):4273-4278. PubMed ID: 39307763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Guidelines for construction of traditional Chinese medicine pharmacovigilance system in medical institutions].
    Liu FM; Zhang L; Li YY; Wang ZF; Zhao XX; Cui X; Wei RL; Yang S; Wang LX; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2024 Aug; 49(16):4266-4272. PubMed ID: 39307762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacovigilance guidelines for clinical application of traditional Chinese medicine injections].
    Fu CK; Liu H; Wang LX; Zou YH; Li MQ; Lin YM; Sun WH; Wei X; Hu YE; Xie YM; Li YY
    Zhongguo Zhong Yao Za Zhi; 2024 Aug; 49(16):4279-4284. PubMed ID: 39307764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interpretation of Technical Specifications for Revision of Safety Information in Marketed Chinese Patent Medicine Instructions].
    Zhang XM; Lin ZJ; Zhang B; Sa RN; Lyu JT; Wu H; Li YL; Xu HZ; Huang ZK; Guo YB; Su XF; Duan XJ
    Zhongguo Zhong Yao Za Zhi; 2022 Jan; 47(2):295-300. PubMed ID: 35178970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Technical specification for Instructions for Clinical Application of Chinese Patent Medicines in China Association of Chinese Medicine].
    Zhang XM; Sa RN; Zhang B; Zhang D; Lyu JT; Duan XJ; Lin ZJ; Guo YB
    Zhongguo Zhong Yao Za Zhi; 2021 Sep; 46(17):4563-4568. PubMed ID: 34581062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Present situation and prospect of quality standardization of Chinese patent medicines].
    Gao XM; Zhang JJ; Zhang DQ; Wang JX; Ou LN; Chen SH
    Zhongguo Zhong Yao Za Zhi; 2007 May; 32(9):868-72. PubMed ID: 17639993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Guidelines for post-marketing research on clinical effectiveness of Chinese patent medicines].
    Wang ZF; Xie YM; Tang JY; Zhang JH; Sun X; Yang ZQ
    Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(3):842-848. PubMed ID: 38621888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Series of group standards of Technical Specifications for Revision of Safety Information in Marketed Chinese Patent Medicine Instructions].
    Zhang B; Zhang XM; Lin ZJ; Sa RN; Lyu JT; Wu H; Li YL; Xu HZ; Huang ZK; Guo YB; Su XF; Duan XJ
    Zhongguo Zhong Yao Za Zhi; 2022 Jan; 47(2):285-294. PubMed ID: 35178969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research on evaluation criteria over quality as core index of high grade Chinese patent medicine].
    Liu Y; Yu HC; Zhang J; Chen C; Cheng JT; Song ZH; Liu A
    Zhongguo Zhong Yao Za Zhi; 2018 Nov; 43(21):4356-4360. PubMed ID: 30583641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Construction of model for multidimensional evaluation of value and risk of Chinese patent medicine].
    Li G; Li ZK; Yang HJ; Zhan ZL; Li HM; Tang SH
    Zhongguo Zhong Yao Za Zhi; 2021 Mar; 46(5):1284-1292. PubMed ID: 33787124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reporting standards for expert consensus on clinical practice of Chinese patent medicines of China Association of Chinese Medicine].
    Mo M; Liao X; Zhang XX; Li B; Chen W; Zhao GZ; Guo YB
    Zhongguo Zhong Yao Za Zhi; 2019 Jun; 44(12):2644-2651. PubMed ID: 31359735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Guidance of instructions for compiling expert consensus on clinical practice of Chinese patent medicine of China Association of Chinese Medicine].
    Mo M; Zhang XX; Liao X; Li B; Chen W; Zhao GZ; Guo YB
    Zhongguo Zhong Yao Za Zhi; 2019 Jun; 44(12):2652-2656. PubMed ID: 31359736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis and reflection on current situation of Chinese patent medicine for children in China].
    Liu H; Chen YJ; Fu QF; Zhao SY; Nie LH; Ma R; Rong P
    Zhongguo Zhong Yao Za Zhi; 2024 Apr; 49(7):1966-1973. PubMed ID: 38812209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Scoping review of clinical evidence of Chinese patent medicines for digestive system diseases in children].
    Wu X; Dai ZQ; Xu SM; Li MM; Liao X
    Zhongguo Zhong Yao Za Zhi; 2022 Aug; 47(15):4248-4255. PubMed ID: 36046915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis on formulation regularity and characteristics of acne-relieving Chinese medicinal health products and Chinese patent medicines].
    Zhang R; Hou XJ; Zhang Y; Wang CD; Zhao F; Zhao DP; Wang LY; Zhang JJ
    Zhongguo Zhong Yao Za Zhi; 2021 Jul; 46(13):3234-3239. PubMed ID: 34396742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preliminary study on general safe medication regularity of Chinese patent orthopedic medicines based on adverse reaction/event literature analysis].
    Wang YG; Shi XY; Jin R; Li HY; Kong XW; Qiao YJ
    Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(6):1192-7. PubMed ID: 26226769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacovigilance of traditional Chinese medicine according to theory of preventive treatment of disease].
    Ri-Na SA; Bing Z
    Zhongguo Zhong Yao Za Zhi; 2020 Sep; 45(17):4273-4276. PubMed ID: 33164414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.